| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Yeramian Patrick D is a Chief Medical Officer at Amylyx Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 2,812 | $16.33 | $45,914.62 | -1.3% | -83.6% | -77.0% | |
| May 15, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 11,965 | $29.03 | $347,358.31 | -5.4% | -25.4% | -93.4% | |
| Apr 17, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 49,579 | $30.54 | $1,513,942.35 | -10.6% | -26.2% | -93.5% | |
| Mar 16, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 54,627 | $31.87 | $1,741,200.40 | -15.3% | -22.4% | -89.9% | |
| Jan 6, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 2,034 | $36.30 | $73,831.01 | -0.5% | -21.4% | -54.5% |